Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

So far, only the detection of 14-3-3 proteins in cerebrospinal fluid (CSF) has been accepted as diagnostic criterion for Creutzfeldt-Jakob disease (CJD). However, this assay cannot be used for screening because of the high rate of false-positive results, whereas patients with variant CJD are often negative for 14-3-3 proteins. The aim of this study was to compare the spot patterns of CSF by 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE) to search for a CJD-specific spot pattern. We analyzed the CSF of 28 patients {[}11 CJD, 9 Alzheimer's disease ( AD), 8 nondemented controls (NDC)] employing 2D-PAGE which was optimized for minimal volumes of CSF (0.1 ml; 7-cm strips). All samples were run at least three times, gels were silver stained and analyzed by an analysis software and manually revised. We could consistently match 268 spots which were then compared between all groups. By the use of 5 spots, we were able to differentiate CJD from AD or NDC with a sensitivity of 100%. CJD could also be distinguished from both groups by using a heuristic clustering algorithm of 2 spots. We conclude that this proteomic approach can differentiate CJD from other diseases and may serve as a model for other neurodegenerative diseases. Copyright (C) 2007 S. Karger AG, Basel

Ion dynamics in perturbed quadrupole ion traps

Published versio

Maturation behavior of Maxi Gala grafetd on two rootstocks by no Destructive Method.

The evaluation of the maturation in apple orchards is checked using destructive methods, sampling fruits and analyzing them in the laboratory, making the process slow and expensive. The use of not destructive method to determine fruit maturation in the orchard could accelerate delivery of results and help in determining harvest time, because non-destructive data would allow to verify the maturation on different blocks in the orchard. The aim of this work was to chart fruit maturation in 'Maxi Gala' grafted on two different rootstocks, using destructive and not destructive methods. The non-destructive method used was the portable DA-Meter. The trial was realized at Vacaria, southern Brazillocated 28,44 S and 50,85 W. The samples were harvested on two orchards during the seasons 2014/15 and 2015/16, during six weeks before harvest from January until the second week of February. The sampling was realized in five different points of the orchard, on rootstocks M.9 or Marubakaido with M.9 interstem. Ten-apple samples were collected weekly in each point in the orchard and then evaluated by destructive method (flesh firmness, starch degradation, total soluble solids and acidity) and the not destructive method (DA-Meter). For both seasons, the evolution of the fruit maturation of Maxi Gala showed a similar progression for both rootstocks. The non-destructive method correlated well with the traditional destructive methods, making it a tool for more practical and easy determination of the harvest date

Path integrals on a flux cone

This paper considers the Schroedinger propagator on a cone with the conical singularity carrying magnetic flux (``flux cone''). Starting from the operator formalism and then combining techniques of path integration in polar coordinates and in spaces with constraints, the propagator and its path integral representation are derived. "Quantum correction" in the Lagrangian appears naturally and no a priori assumption is made about connectivity of the configuration space.Comment: LaTeX file, 9 page

Tau protein, A beta 42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

The intra vitam diagnosis of dementia with Lewy bodies (DLB) is still based on clinical grounds. So far no technical investigations have been available to support this diagnosis. As for tau protein and beta-amyloid((1-42)) (Abeta42), promising results for the diagnosis of Alzheimer's disease ( AD) have been reported; we evaluated these markers and S-100B protein in cerebrospinal fluid (CSF), using a set of commercially available assays, of 71 patients with DLB, 67 patients with AD and 41 nondemented controls (NDC) for their differential diagnostic relevance. Patients with DLB showed significantly lower tau protein values compared to AD but with a high overlap of values. More prominent differences were observed in the comparison of DLB patients with all three clinical core features and AD patients. Abeta42 levels were decreased in the DLB and AD groups versus NDC, without significant subgroup differences. S-100B levels were not significantly different between the groups. Tau protein levels in CSF may contribute to the clinical distinction between DLB and AD, but the value of the markers is still limited especially due to mixed pathology. We conclude that more specific markers have to be established for the differentiation of these diseases. Copyright (C) 2005 S. Karger AG, Basel